Consistently, recent findings obtained in different carcinoma cell lines have shown that the induced expression of FGFR2c in tumor cells poorly expressing this FGFR2 variant correlates with enhanced in vitro tumorigenicity and invasiveness, while its depletion in highly-expressing cells represses these features [10–12]. The gene discussed is FGFR2; the disease is neoplasm.